Enzyme News and Research

RSS

AI could accelerate commercialization of bio-based chemical manufacturing

The era of "biomanufacturing", in which microbes, not petroleum, produce chemical products, is one step closer. A KAIST research team has analyzed the key challenges limiting the commercialization of biomanufacturing and proposed an AI-driven strategy for industrialization.

13 Jul 2026

New study tracks early genetic changes in hepatitis E virus

Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability.

13 Jul 2026

Engineered ribozyme repairs broken RNA to explain origins of life

In most modern cells, DNA stores the genetic blueprint, and relies on proteins to replicate, repair and build from those blueprints.

13 Jul 2026

Study links oxalate to systemic inflammation and heart damage

Oxalic acid might do more than just contribute to the formation of kidney stones — it may also be an underappreciated driver of inflammation and heart damage in people with impaired kidney function.

11 Jul 2026

VOYAGER electronic pipettes support breakthroughs in analgesia research

Purdue University researchers use VOYAGER pipettes to enhance drug discovery for non-opioid chronic pain therapies, improving assay throughput and accuracy.

From INTEGRA Biosciences 9 Jul 2026

Study identifies new target for Parkinson's disease neuroprotection

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

8 Jul 2026

Biohub researchers use artificial intelligence to uncover new psoriasis targets

Biohub researchers performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis.

8 Jul 2026

Study reveals why patients with rare leukemia develop resistance to tagraxofusp

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of leukemia, called blastic plasmacytoid dendritic cell neoplasm (BPDCN), eventually develop resistance to tagraxofusp, the first Food and Drug Administration-approved treatment for this disease.

7 Jul 2026

Sustainable oyster meat extract may reduce human intestinal inflammation

Ongoing research provides evidence that readily-available and sustainable oyster meat extract may have powerful anti-inflammatory effects on human intestinal cells.

7 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

6 Jul 2026

New breast cancer classification system predicts immunotherapy response success

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

3 Jul 2026

Study reveals how specific aging cells help repair injured tendons

Tendon injuries, though very common, frequently heal with scar tissue, which is less flexible and more prone to future injury.

3 Jul 2026

USC scientists target brain inflammation to prevent Alzheimer's disease

An interdisciplinary team at the USC Center for Personalized Brain Health (CPBH) is targeting a family of enzymes that can increase the risk of inflammation in the brains of people with the APOE4 gene variation-the most significant genetic risk factor for late-onset Alzheimer's-as a way to prevent the disease.

2 Jul 2026

Reversing macrophage metabolism may improve cancer immunotherapy outcomes

Tumor-associated macrophages (TAMs) are among the most abundant immune cells in the tumor microenvironment.

1 Jul 2026

New bacterial enzyme blueprint could accelerate cancer treatment development

A team of researchers at the University of Warwick and Monash University has solved a puzzle that's stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies.

1 Jul 2026

Cryo-EM microscopy uncovers structure of bacteria behind gum disease

Periodontal (gum) disease is one of the most prevalent diseases worldwide, caused by the bacterium Porphyromonas gingivalis (P. gingivalis). In Japan alone, approximately 80% of adults over 30 years old are affected or considered at risk.

30 Jun 2026

Fiber blend relieves constipation and improves stool consistency

A recent study found that a combination of dietary fibers effectively alleviated chronic constipation, enhancing bowel function and stool quality in adults.

30 Jun 2026

New strategy restores vancomycin effectiveness against resistant bacteria

Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone.

29 Jun 2026

Okra supplements may lower cholesterol and inflammation markers in diabetes

...

29 Jun 2026

Study links sedentary lifestyle to early mitochondrial dysfunction in adults

Researchers at the University of Colorado Anschutz have found that healthy yet sedentary individuals show a significant, coordinated drop in muscle mitochondrial function that may precede the development of major diseases like cancer, diabetes, and Alzheimer's.

29 Jun 2026